Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28697232 | 0.86 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL11035476 | 0.80 | — | — | |
| SCHEMBL11032565 | 0.76 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL10881978 | 0.75 | MEN1 (0.30) | ALDH1A1 | |
| SCHEMBL11034723 | 0.73 | CAD (0.32) | ALDH1A1 | |
| SCHEMBL6036958 | 0.73 | MEN1 (0.40) | ALDH1A1 | |
| SCHEMBL9710715 | 0.73 | — | — | |
| SCHEMBL11032591 | 0.72 | MTOR (0.36) | ALDH1A1 | |
| SCHEMBL10710775 | 0.72 | MEN1 (0.35) | ALDH1A1 | |
| SCHEMBL11036720 | 0.71 | EPHX1 (0.39) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4777515-B2 | — | — | 2011-09-21 | — | — | JP | claimed |
| US-7498332-B2 | Therapy for cerebral vasospasm | DUKE UNIVERSITY (US) | 2009-03-03 | — | — | US | claimed |
| EP-1124950-B1 | Morpholino based p53 antisense oligonucleotide, and uses thereof | AVI BIOPHARMA INC (US) | 2006-07-12 | — | — | EP | claimed |
| WO-2005049811-A1 | RADIOMINETIC METHOD OF PRODUCING A RODENT XENOGRAFT MODEL HAVING HUMANIZED MAMMARY FAT PAD | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 2005-06-02 | — | — | WO | claimed |
| US-20020160001-A1 | Therapy for cerebral vasospasm | DUKE UNIVERSITY | 2002-10-31 | — | — | US | claimed |
| JP-2002528464-A | — | — | 2002-09-03 | — | — | JP | claimed |
| US-6365577-B1 | p53 antisense agent and method | AVI BIOPHARMA, INC. | 2002-04-02 | — | — | US | claimed |
| EP-1124950-A2 | p53 ANTISENSE AGENT AND METHOD | Avi Biopharma, Inc. (US) | 2001-08-22 | — | — | EP | claimed |
| WO-2000024885-A2 | p53 MORPHOLINO-BASED ANTISENSE | AVI BIOPHARMA, INC. (US) | 2000-05-04 | — | — | WO | claimed |
| US-20180028677-A1 | Peptides for Assisting Delivery Across the Blood Brain Barrier | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2018-02-01 | — | — | US | disclosed |
| US-9757470-B2 | Peptides for assisting delivery across the blood brain barrier | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2017-09-12 | — | — | US | disclosed |
| US-20140294727-A1 | PEPTIDES FOR ASSISTING DELIVERY ACROSS THE BLOOD BRAIN BARRIER | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2014-10-02 | — | — | US | disclosed |
| US-8748567-B2 | Method for delivery across the blood brain barrier | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2014-06-10 | — | — | US | disclosed |
| US-7811587-B2 | Botulinum toxin therapy for neuropsychiatric disorders | ALLERGAN, INC. (US) | 2010-10-12 | — | — | US | disclosed |
| US-20010053369-A1 | Treating a movement disorder by intracranial administration of a neurotoxin, especially a botulinium toxin | DONOVAN STEPHEN (US) | 2001-12-20 | — | — | US | disclosed |
| WO-2001095924-A2 | METHOD FOR TREATING A MOVEMENT DISORDER | ALLERGAN, INC. (US) | 2001-12-20 | — | — | WO | disclosed |
| US-6306403-B1 | Method for treating parkinson's disease with a botulinum toxin | ALLERGAN SALES, INC. | 2001-10-23 | — | — | US | disclosed |
| EP-1124950-A2 | p53 ANTISENSE AGENT AND METHOD | Avi Biopharma, Inc. (US) | 2001-08-22 | — | — | EP | disclosed |
| WO-2000024885-A2 | p53 MORPHOLINO-BASED ANTISENSE | AVI BIOPHARMA, INC. (US) | 2000-05-04 | — | — | WO | disclosed |
| EP-0331505-A1 | A method for purification of liposome composition | Takeda Chemical Industries, Ltd. (JP) | 1989-09-06 | — | — | EP | disclosed |